Literature DB >> 15628972

Decreased lipid efflux and increased susceptibility to cholesterol-induced apoptosis in macrophages lacking phosphatidylcholine transfer protein.

Juan M Baez1, Ira Tabas, David E Cohen.   

Abstract

Macrophages are the predominant cellular component of atherosclerotic lesions, where they scavenge oxidatively modified lipoproteins while defending themselves against cholesterol-induced cytotoxicity by adaptive mechanisms that depend in part on the synthesis, distribution and efflux of phosphatidylcholines. PC-TP (phosphatidylcholine transfer protein) is a START (steroidogenic acute regulatory protein-related lipid transfer) domain protein that catalyses the intermembrane transfer of phosphatidylcholines and promotes apolipoprotein AI-mediated lipid efflux when overexpressed in the cytosol of Chinese-hamster ovary cells. To explore a role for PC-TP in the adaptive responses of macrophages to cholesterol loading, we utilized peritoneal macrophages from mice with homozygous disruption of the gene encoding PC-TP (Pctp(-/-)) and wild-type littermate controls. PC-TP was abundantly expressed in macrophages from wild-type but not Pctp(-/-) mice. In cholesteryl ester-loaded macrophages from Pctp(-/-) mice, the apolipoprotein AI-mediated efflux of phospholipids and cholesterol was decreased. This could be attributed to proportional decreases in the expression levels of ATP-binding cassette A1. Also, in response to free cholesterol loading, the absence of PC-TP from macrophages was associated with marked increases in apoptotic cell death. These findings suggest that PC-TP in macrophages may serve an atheroprotective role by defending against cholesterol-induced cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15628972      PMCID: PMC1186693          DOI: 10.1042/BJ20041899

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  START: a lipid-binding domain in StAR, HD-ZIP and signalling proteins.

Authors:  C P Ponting; L Aravind
Journal:  Trends Biochem Sci       Date:  1999-04       Impact factor: 13.807

2.  cDNA cloning and tissue-specific expression of the phosphatidylcholine transfer protein gene.

Authors:  T B Geijtenbeek; A J Smith; P Borst; K W Wirtz
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

3.  Apolipoprotein-mediated cellular cholesterol and phospholipid efflux depend on a functional Golgi apparatus.

Authors:  A J Mendez; L Uint
Journal:  J Lipid Res       Date:  1996-12       Impact factor: 5.922

4.  Mice without phosphatidylcholine transfer protein have no defects in the secretion of phosphatidylcholine into bile or into lung airspaces.

Authors:  A van Helvoort; A de Brouwer; R Ottenhoff; J F Brouwers; J Wijnholds; J H Beijnen; A Rijneveld; T van der Poll; M A van der Valk; D Majoor; W Voorhout; K W Wirtz; R P Elferink; P Borst
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

Review 5.  Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis.

Authors:  M S Brown; J L Goldstein
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

6.  Effects of intracellular free cholesterol accumulation on macrophage viability: a model for foam cell death.

Authors:  G Kellner-Weibel; W G Jerome; D M Small; G J Warner; J K Stoltenborg; M A Kearney; M H Corjay; M C Phillips; G H Rothblat
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-03       Impact factor: 8.311

7.  Macrophage-targeted CTP:phosphocholine cytidylyltransferase (1-314) transgenic mice.

Authors:  W Tang; A Walsh; I Tabas
Journal:  Biochim Biophys Acta       Date:  1999-03-25

8.  Apolipoprotein A-I stimulates secretion of apolipoprotein E by foam cell macrophages.

Authors:  D Rees; T Sloane; W Jessup; R T Dean; L Kritharides
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

9.  Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages.

Authors:  V A Fadok; D R Voelker; P A Campbell; J J Cohen; D L Bratton; P M Henson
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

10.  A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V.

Authors:  I Vermes; C Haanen; H Steffens-Nakken; C Reutelingsperger
Journal:  J Immunol Methods       Date:  1995-07-17       Impact factor: 2.303

View more
  7 in total

1.  A polymorphism in New Zealand inbred mouse strains that inactivates phosphatidylcholine transfer protein.

Authors:  Huei-Ju Pan; Diana S Agate; Benjamin L King; Michele K Wu; Steven L Roderick; Edward H Leiter; David E Cohen
Journal:  FEBS Lett       Date:  2006-10-06       Impact factor: 4.124

2.  Targeted disruption of steroidogenic acute regulatory protein D4 leads to modest weight reduction and minor alterations in lipid metabolism.

Authors:  Joshua J Riegelhaupt; Marc P Waase; Jeanne Garbarino; Daniel E Cruz; Jan L Breslow
Journal:  J Lipid Res       Date:  2009-11-17       Impact factor: 5.922

Review 3.  Structure and function of phosphatidylcholine transfer protein (PC-TP)/StarD2.

Authors:  Keishi Kanno; Michele K Wu; Erez F Scapa; Steven L Roderick; David E Cohen
Journal:  Biochim Biophys Acta       Date:  2007-04-12

4.  Phosphatidylcholine induces apoptosis of 3T3-L1 adipocytes.

Authors:  Hailan Li; Jong-Hyuk Lee; Su Yeon Kim; Hye-Young Yun; Kwang Jin Baek; Nyoun Soo Kwon; Yoosik Yoon; Ji Hoon Jeong; Dong-Seok Kim
Journal:  J Biomed Sci       Date:  2011-12-07       Impact factor: 8.410

5.  Trait correlated expression combined with eQTL and ASE analyses identified novel candidate genes affecting intramuscular fat.

Authors:  Yan Liu; Huan Long; Simin Feng; Tingting Ma; Mufeng Wang; Lizhu Niu; Xinyi Zhang; Lianni Wang; Yu Lei; Yilong Chen; Qiankun Wang; Xuewen Xu
Journal:  BMC Genomics       Date:  2021-11-08       Impact factor: 3.969

6.  Novel associations of nonstructural Loci with paraoxonase activity.

Authors:  Ellen E Quillen; David L Rainwater; Thomas D Dyer; Melanie A Carless; Joanne E Curran; Matthew P Johnson; Harald H H Göring; Shelley A Cole; Sue Rutherford; Jean W Maccluer; Eric K Moses; John Blangero; Laura Almasy; Michael C Mahaney
Journal:  J Lipids       Date:  2012-04-17

7.  Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376c.

Authors:  Leonard C Edelstein; Lukas M Simon; Raúl Teruel Montoya; Michael Holinstat; Edward S Chen; Angela Bergeron; Xianguo Kong; Srikanth Nagalla; Narla Mohandas; David E Cohen; Jing-fei Dong; Chad Shaw; Paul F Bray
Journal:  Nat Med       Date:  2013-11-10       Impact factor: 53.440

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.